http://rdf.ncbi.nlm.nih.gov/pubchem/patent/YU-67102-A

Outgoing Links

Predicate Object
assignee http://rdf.ncbi.nlm.nih.gov/pubchem/patentassignee/MD5_27a71ddaaa2f5a8c228fc6cb3f3b3098
classificationCPCInventive http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61P25-24
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61P25-14
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61P25-18
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61P25-16
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61P25-00
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61P25-06
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61P25-04
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61P3-04
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61P15-00
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61P25-30
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61P25-28
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61P25-34
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61K31-5375
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61K31-535
classificationIPCInventive http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61P15-00
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61P25-16
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61P25-14
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61P25-24
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61P25-30
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61P25-34
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61K31-5375
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/C07D265-32
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61P3-04
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61P25-06
filingDate 2002-09-06-04:00^^<http://www.w3.org/2001/XMLSchema#date>
inventor http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_1e4c796cc827ee8e02d02029f2d544c0
http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_a22e058524203ec4dfb58bd709b07a77
http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_bf95334b8291528e67b74d956b24b662
publicationDate 2004-12-31-04:00^^<http://www.w3.org/2001/XMLSchema#date>
publicationNumber YU-67102-A
titleOfInvention PHARMACEUTICAL ACTIVE MORFOLINOL
abstract The compound (+) - (2S, 3S) -2- (3-chlorophenyl) -3,5,5-trimethyl-2-morpholinol and its pharmaceutically acceptable salts and solvates, pharmaceutical preparations containing them are described, and also described and a method of treating depression, attention deficit hyperactivity disorder (ADHD), obesity, migraine, pain, sexual dysfunction, Parkinson's disease, Alzheimer's disease, cocaine addiction or nicotine-containing products (especially tobacco) using this compound, its salts, solvates [Herewith described compound is (+) - (2S, 3S) -2- (3-chloryphenyl) -3,5,5-trymethyl-2-morpohylinol and its pharmaceutically acceptable salts and solvates, pharmaceutical preparations containing them, and there is also a description of the method for treating depression, hyperactivity disorder with lessening of attention (ADHD), obesity, migraine, pain, sexual dysfunction, Parkinson's disease and Alzheimer's syndrome, cocaine addiction or of products containing nicotine (particular ly tobacco) by means of using this compound, its salts, solvates and preparations.
priorityDate 1998-01-21-04:00^^<http://www.w3.org/2001/XMLSchema#date>
type http://data.epo.org/linked-data/def/patent/Publication

Incoming Links

Predicate Subject
isDiscussedBy http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID419556542
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID421225826
http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID12751541
http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID89594

Total number of triples: 39.